Objective: To analyze human articular chondrocyte celf-associated matrix ag
grecan, hyaluronan (HA) and type II collagen metabolism using flow cytometr
y; and to compare the results obtained for aggrecan with classic (35)Sulfat
e incorporation methods and an enzyme linked immunosorbent assay (ELISA).
Design: Human articular chondrocytes obtained from five donors were culture
d In gelled agarose and tested for their response to different concentratio
ns of interleukin-1 beta (IL-1 beta). Synthesis and distribution of aggreca
n in the cell-associated matrix (CAM), in the interterritorial matrix and i
n the nutrient medium of the chondrocytes in culture were analyzed using (3
5)Sulfate incorporation. The results were expressed incorporated in aggreca
n per 1 x 10(6) cells/h. Flow cytometry with FITC-conjugated monoclonal ant
ibodies against aggrecan and as pg SO4 incorporated in aggrecan per 1 x 10(
6) cells/h. Flow cytometry with FITC-conjugated monoclonal antibodies again
st aggrecan and type II collagen, and with the biotinylated hyaluronic acid
binding protein (b-HABP), was used to investigate the synthesis and accumu
lation of aggrecan, type I I collagen and HA in the CAM of the cultured cel
ls. The packing of these macromolecules in the CAM of the chondrocytes, was
assessed by measuring the mean fluorescence intensity (MFI) of the cell sa
mple due to the binding of the specific monoclonal antibodies or b-HABP use
d. ELISA was used in parallel to quantify CAM aggrecans after these macromo
lecules were brought into solution with guanidinium chloride. Detection of
aggrecan by flow cytometry was compared with S-35-incorporation in chondroc
ytes from two subjects and with. ELISA in a further two donors.
Results. IL-1 beta suppressed aggrecan synthesis by chondrocytes in agarose
. An IL-1 beta dose-dependent suppression of S-35-aggrecan in the CAM refle
cted the changes in the interterritorial matrix. IL-1 beta -induced aggreca
n breakdown was followed by a rise in S-35-aggrecan metabolites In the incu
bation media of the calls in culture. Flow cytometry and ELISA confirmed th
is decreased accumulation of aggrecan in the CAM of the chondrocytes. The r
esults obtained with flow cytometry were closely related to those obtained
with ELISA. on the other hand, indirectly measures the glycosaminoglycan co
ntent of the aggrecan and does not necessarily reflect the absolute amount
of aggrecan molecules. Therefore, the effects of IL-1 beta on cell-associat
ed aggrecan, where assessed with S-35-incorporation, did not correlate with
the results of the flow cytometric assays. Flow cytometry enabled the dete
ction of an impaired synthesis and accumulation of HA and of type II collag
en in the CAM of the cultured chondrocytes, IL-1 beta -induced changes in C
AM agrecan and hyaluronan closely agreed.
Conclusions. Flow cytometry offers an efficient tool to study the metabolis
m of the chondrocyte CAM. The MFI has been used as a parameter to quantify
the ECM molecules in the CAM. (C) 2001 OsteoArthritis Research Society Inte
rnational.